Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Protagonist Therapeutics, Inc. (PTGX) had Tangible Shareholders Equity of $655.47M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$56.37M |
|
$3.78M |
|
-- |
|
$56.37M |
|
$60.02M |
|
$-3.65M |
|
$5.93M |
|
$2.28M |
|
$2.28M |
|
$3.78M |
|
$3.78M |
|
$3.78M |
|
$3.78M |
|
$-3.65M |
|
$-3.83M |
|
65.09M |
|
70.49M |
|
$0.06 |
|
$0.05 |
|
| Balance Sheet Financials | |
$613.46M |
|
$3.78M |
|
$84.00M |
|
$697.46M |
|
$34.55M |
|
-- |
|
$7.44M |
|
$41.99M |
|
$655.47M |
|
|
Tangible Shareholders Equity |
$655.47M |
$655.47M |
|
64.23M |
|
| Cash Flow Statement Financials | |
$-48.94M |
|
$90.89M |
|
$23.37M |
|
$128.68M |
|
$194.00M |
|
$65.32M |
|
$14.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-6.47% |
|
-6.47% |
|
-- |
|
4.05% |
|
6.71% |
|
$-49.16M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
1.05 |
|
85.68 |
|
0.58% |
|
0.58% |
|
0.54% |
|
0.58% |
|
$10.21 |
|
$-0.70 |
|
$-0.69 |
|